Managing Nausea with QTc >600 ms

Immediate Management Priorities

The American College of Cardiology recommends stopping any current antiemetics that prolong QTc, particularly 5-HT3 antagonists, droperidol, and domperidone, in patients with QTc >600 ms 2, 3, 4
Review and discontinue or minimize all other QT-prolonging drugs, including antimicrobials and antipsychotics, to reduce the risk of torsades de pointes 3, 4
Consult crediblemeds.org for a comprehensive list of medications to avoid in patients with QTc >600 ms 2

Maintain potassium levels >4.0 mEq/L to reduce the risk of torsades de pointes, as hypokalemia significantly increases this risk 2, 4, 1
Administer IV magnesium sulfate 2g (10 mL) regardless of serum magnesium level, as this is first-line therapy for preventing torsades de pointes 2, 4, 1

Implement continuous cardiac monitoring until QTc normalizes to <500 ms, and obtain serial ECGs to track QTc trends 2, 1
Be prepared for emergent defibrillation if sustained ventricular arrhythmias occur 2

The American College of Cardiology recommends metoclopramide 10 mg IV/PO every 6-8 hours as first-line for patients with prolonged QTc, as it does not cause QT prolongation 1
Prochlorperazine 5-10 mg IV/PO is generally considered safe regarding QTc, though use with caution 1
Lorazepam 0.5-2 mg IV/PO does not prolong the QT interval and can be used safely 5

IV magnesium sulfate 2g bolus is immediate first-line therapy for torsades de pointes, followed by overdrive transvenous pacing to heart rate 90-110 bpm if torsades recurs 2, 4, 5
Non-synchronized defibrillation is recommended for sustained ventricular arrhythmias with hemodynamic instability 2, 5

Female gender is a higher baseline risk for drug-induced torsades, and bradycardia or heart block significantly increases arrhythmia risk 4, 5, 2
Congestive heart failure worsens prognosis, and concomitant use of multiple QT-prolonging drugs has a synergistic effect 4, 2

In cancer patients with chemotherapy-induced nausea, nausea, vomiting, and diarrhea cause potassium and magnesium losses that further prolong QTc, and metoclopramide is recommended as first-line 3, 1
When antiemetic efficacy is inadequate, consult cardiology before using any QT-prolonging alternatives, and consider combination of metoclopramide with lorazepam for additive effect without QT risk 1, 5